6919 KangPei Biotech Annual General Meeting Resolutions
KangPei Biotech approved its 2025 financial statements, loss compensation plan, board re-election, and employee stock incentive plans at the AGM on May 22, 2026.
📋 Article Processing Timeline
- 📰 Published: May 23, 2026 at 06:31
- 🔍 Collected: May 23, 2026 at 06:31 (0 min after Published)
- 🤖 AI Analyzed: May 31, 2026 at 21:02 (206h 30m after Collected)
On May 22, 2026, KangPei Biotech held its annual general meeting and passed several key resolutions: approval of the 2025 loss compensation plan and financial statements, completion of the full re-election of the board of directors, amendments to the employee restricted stock issuance plan, issuance of 2026 restricted employee shares, and the removal of non-compete restrictions for new directors.
FAQ
What was decided at KangPei's AGM?
Resolutions included financial statement approval, board re-election, and new share issuance for employees.